Predicting invasive fungal disease due to Candida species in non-neutropenic, critically ill, adult patients in United Kingdom critical care units
David A Harrison(The University of Melbourne), Rosemary A. Barnes(Innsbruck Medical University), H Muskett(Intensive Care National Audit & Research Centre), Krishna Patel(Cleveland Clinic), Sheila Harvey(St Thomas' Hospital), Kathy Rowan(Intensive Care National Audit & Research Centre), Christopher C. Kibbler(Radboud University Medical Center), Elizabeth Allen(London School of Hygiene & Tropical Medicine), Sharmistha Biswas(Malda Medical College and Hospital), Jonathan Edgeworth(St Thomas' Hospital), Jason Shahin(McGill University), Neil Soni(Chelsea and Westminster Hospital)
Cited by 29
Related Papers
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
|Clinical Infectious Diseases|2008|4.9k
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
|Clinical Infectious Diseases|2019|2.8k
Trial of Early, Goal-Directed Resuscitation for Septic Shock
|New England Journal of Medicine|2015|1.6k
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline
|Clinical Microbiology and Infection|2018|1.5k